Search Results - "Besag, Frank MC"

Refine Results
  1. 1

    Epilepsy in patients with autism: links, risks and treatment challenges by Besag, Frank Mc

    Published in Neuropsychiatric disease and treatment (01-01-2018)
    “…Autism is more common in people with epilepsy, approximately 20%, and epilepsy is more common in people with autism with reported rates of approximately 20%…”
    Get full text
    Journal Article
  2. 2

    Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures by Besag, Frank Mc, Patsalos, Philip N

    Published in Neuropsychiatric disease and treatment (01-01-2016)
    “…Perampanel, a selective noncompetitive antagonist at the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, is highly effective in a wide…”
    Get full text
    Journal Article
  3. 3

    New developments in the treatment of partial-onset epilepsy by Besag, Frank Mc, Patsalos, Philip N

    Published in Neuropsychiatric disease and treatment (01-01-2012)
    “…Although most people presenting with partial-onset seizures will achieve control with antiepileptic medication, a considerable minority will have…”
    Get full text
    Journal Article
  4. 4

    Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II by Cortese, Samuele, Besag, Frank MC, Clark, Bruce, Hollis, Chris, Kilgariff, Joe, Moreno, Carmen, Nicholls, Dasha, Wilkinson, Paul, Woodbury-Smith, Marc, Sharma, Aditya

    Published in Journal of Psychopharmacology (01-04-2024)
    “…As Faculty of the British Association for Psychopharmacology course on child and adolescent psychopharmacology, we present here what we deem are the most…”
    Get full text
    Book Review Journal Article
  5. 5

    Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I by Cortese, Samuele, Besag, Frank MC, Clark, Bruce, Hollis, Chris, Kilgariff, Joe, Moreno, Carmen, Nicholls, Dasha, Wilkinson, Paul, Woodbury-Smith, Marc, Sharma, Aditya

    Published in Journal of Psychopharmacology (01-04-2024)
    “…As Faculty of the British Association for Psychopharmacology course on child and adolescent psychopharmacology, we present here what we deem are the most…”
    Get full text
    Book Review Journal Article
  6. 6

    Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course by Cortese, Samuele, Besag, Frank MC, Clark, Bruce, Hollis, Chris, Kilgariff, Joseph, Moreno, Carmen, Nicholls, Dasha, Wilkinson, Paul, Woodbury-Smith, Marc, Sharma, Aditya

    Published in Journal of Psychopharmacology (01-02-2023)
    “…The British Association for Psychopharmacology course on child and adolescent psychopharmacology has been run for more than 20 years and is currently a very…”
    Get full text
    Book Review Journal Article
  7. 7

    Valproate-Associated Parkinsonism: A Critical Review of the Literature by Brugger, Florian, Bhatia, Kailash P., Besag, Frank M. C.

    Published in CNS drugs (01-06-2016)
    “…Valproate was first approved as an antiepileptic drug in 1962 and has since also become established as a mood stabiliser and as prophylaxis for migraine. In…”
    Get full text
    Journal Article
  8. 8

    Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review by Besag, Frank MC, Vasey, Michael J, Lao, Kim SJ, Chowdhury, Uttom, Stern, Jeremy S

    Published in Journal of Psychopharmacology (01-09-2021)
    “…Background: Tourette syndrome (TS) is a neurodevelopmental disorder characterised by involuntary muscle movements manifesting as motor and vocal tics. In the…”
    Get full text
    Book Review Journal Article
  9. 9

    Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder by Stiefel, Gary, Besag, Frank M.C.

    Published in Drug safety (01-10-2010)
    “…Attention-deficit hyperactivity disorder (ADHD) is a very common condition in children and often extends into the adult years. Drugs such as methylphenidate,…”
    Get full text
    Journal Article
  10. 10

    Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials by Lao, Kim S. J., He, Ying, Wong, Ian C. K., Besag, Frank M. C., Chan, Esther W.

    Published in CNS drugs (01-11-2016)
    “…Background Cariprazine is a novel antipsychotic agent recently approved for treating schizophrenia and bipolar mania in the USA. The sample sizes of published…”
    Get full text
    Journal Article
  11. 11

    Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups by Lao, Kim S.J., Tam, Anthony W.Y., Wong, Ian C.K., Besag, Frank M.C., Man, Kenneth K.C., Chui, Celine S.L., Chan, Esther W.

    Published in Pharmacoepidemiology and drug safety (01-11-2017)
    “…Purpose Antipsychotic‐prescribing patterns remain unclear in Asia. The aims of our study were to investigate prescribing trends of antipsychotic medication in…”
    Get full text
    Journal Article
  12. 12

    Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review by Besag, Frank M.C., Vasey, Michael J., Sharma, Aditya N., Lam, Ivan C.H.

    “…Background: Bipolar disorder (BD) is a cyclic mood disorder characterised by alternating episodes of mania/hypomania and depression interspersed with euthymic…”
    Get full text
    Book Review Journal Article
  13. 13

    Cognitive and Behavioral Outcomes of Epileptic Syndromes: Implications for Education and Clinical Practice by Besag, Frank M. C.

    Published in Epilepsia (Copenhagen) (01-11-2006)
    “…The educational and social progress of a child with epilepsy depends not only on seizure control but also on cognitive and behavioral factors. The various…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Rufinamide for the treatment of Lennox-Gastaut syndrome by Besag, Frank M C

    Published in Expert opinion on pharmacotherapy (01-04-2011)
    “…Lennox-Gastaut syndrome (LGS) is a severe treatment-resistant childhood-onset epilepsy. This review examines the role of the new drug rufinamide for the…”
    Get more information
    Journal Article
  16. 16

    Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy by Piedad, John, Rickards, Hugh, Besag, Frank MC, Cavanna, Andrea E

    Published in CNS drugs (01-04-2012)
    “…Antiepileptic drugs (AEDs) can have both beneficial and adverse psychotropic effects. They act on neurotransmitter systems, neuronal ion permeability and other…”
    Get full text
    Journal Article
  17. 17

    Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial by Scott, Rod C, Besag, Frank MC, Neville, Brian GR

    Published in The Lancet (British edition) (20-02-1999)
    “…Convulsive status epilepticus is the most common neurological medical emergency and has high morbidity and mortality. Early treatment before admission to…”
    Get full text
    Journal Article
  18. 18

    Behavioural effects of the newer antiepileptic drugs: an update by Besag, Frank M C

    Published in Expert opinion on drug safety (01-01-2004)
    “…The negative and positive effects of the nine newer antiepileptic drugs that have received a product licence in the UK or in the US are reviewed. The…”
    Get more information
    Journal Article
  19. 19

    Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs by Ackers, Ruth, Besag, Frank MC, Hughes, Elaine, Squier, Waney, Murray, Macey L, Wong, Ian CK

    Published in Drug safety (01-05-2011)
    “…Background: Patients with epilepsy, including children, have an increased risk of mortality compared with the general population. Antiepileptic drugs (AEDs)…”
    Get full text
    Journal Article
  20. 20